KROS Financing Cash Flow
Keros Therapeutics Inc · Financing Cash Flow
KROS Financing Cash Flow
Latest reported-$384.12Mperiod ending
KROS TTM Cash from Financing ($14.00K → -$384.12M)
TTM financing cash flow
High-resolution chart · PNG
KROS financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -384,122,000 | |
| -380,790,000 | |
| -378,470,000 | |
| 75,705,000 | |
| 231,509,000 | |
| 235,023,000 | |
| 391,821,000 | |
| 385,531,000 | |
| 229,871,000 | |
| 228,080,000 | |
| 178,956,000 | |
| 171,118,000 | |
| 219,417,000 | |
| 227,869,000 | |
| 120,309,000 | |
| 87,309,000 | |
| 38,761,000 | |
| 28,626,000 | |
| 28,550,000 | |
| 140,251,000 | |
| 140,225,000 | |
| 240,292,000 | |
| 296,044,000 | |
| 155,931,000 | |
| 155,928,000 | |
| 55,808,000 | |
| 14,000 |